Dr Mirza is Chief Oncologist at the Dept. of Oncology, Rigshospitalet, Copenhagen University Hospital, Denmark and Medical Director of the Nordic Society of Gynaecologic Oncology-Clinical Trial Unit (NSGO-CTU). He is also Vice-Chairman of the Danish Society of Gynaecologic Oncology (DGCG).

He is author and principal investigator of several phase I, II and III studies and is chair/member of Independent Data Monitoring Committee (IDMC) of several international trials. He is a senior author of national guidelines for the management of endometrial cancer, cervical cancer, vulvar cancer and nonepithelial ovarian cancer, as well as NSGO radiotherapy guidelines for cervical and vulvar cancers.

He is an ESMO Faculty Member, Member of the Danish Society of Clinical Oncology (DSKO), the European Society of Gynaecologic Oncology (ESGO), the International Gynaecologic Cancer Society (IGCS), the European Society of Therapeutic Radiology and Oncology (ESTRO), the Gynaecologic Oncology Group (GOG, USA) and the American Society of Clinical Oncology (ASCO).

Dr Mansoor Raza Mirza has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, Biocad, GSK, Karyopharm, Merck, Mersana, ImmunoGen, Clovis Oncology, Roche, Zai Lab